After the successful conclusion of the first General Assembly Meeting held at Karolinska Institutet, Stockholm, Sweden, from November 22 until 23, 2006, the next General Assembly Meeting was agreed upon to come about November 29 and 30, 2007 in Torino, Italy.

The presentations of the work carried out since the beginning of the year 2006 have been highly impressive and proved the large achievement of cardiological expertise and research potential. The depth of integration that has been achieved so far, is highly striking. Nevertheless, more efforts need to be invested until the synergistic research efforts of more than 21 participating laboratories and SMEs yield one entity aiming to unravel hypertrophic signalling in cardiomyocytes. Bearing in mind the large achievement of potential so far, one can be more than confident that EUGeneHeart will be a successful Integrated Project over the coming years.

The 2nd General Assembly Meeting will take place at the Molecular Biotechnology Center, University of Torino, Italy.